Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

Share this post

Rival versions of the world’s top-selling drug, AbbVie’s Humira, went on sale in Europe on Tuesday, years ahead of similar cut-price copies being available in the United States.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply